<DOC>
	<DOCNO>NCT01728740</DOCNO>
	<brief_summary>To establish bioequivalence Acarbose / Metformin FDC ( 50mg / 500mg ) loose combination Acarbose ( Glucobay ) ( 50mg ) Metformin ( Glucophage ) ( 500mg ) .</brief_summary>
	<brief_title>Bioequivalence Study Acarbose / Metformin FDC</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Body Mass Index ( BMI ) : 18 28 kg/m2 ( inclusive ) Results Glycosylated Hemoglobin A1c ( HbA1c ) value within normal range ( 4.35.6 % , inclusive ) Results 75 g oral glucose tolerance test ( OGTT ) screen show : Blood glucose OGTT &lt; 110 mg/dL . Blood glucose 1 hour glucose load &lt; 180 mg/dL Blood glucose 2 hour glucose load &lt; 140 mg/dL A history relevant diseases internal organ ( diabetes mellitus , Ileus , Ileuslike symptom , disease may significantly jeopardize body system Febrile illness within 1 week drug administration Family history diabetes ( within second degree relationship ) Known drug hypersensitivity idiosyncrasy Known severe allergy , nonallergic drug reaction , multiple drug allergy Habitual medication include Chinese herbal drug Intake drug within 2 week drug administration period 1 Regular daily consumption 1 L usual beer equivalent quantity approximately 40 g alcohol another form Donation 150 mL blood within 4 week screen examination Participation another clinical trial within 4 week screen examination</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Acarbose</keyword>
	<keyword>Metformin</keyword>
	<keyword>FDC</keyword>
</DOC>